Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1

Cancer Research

Volumn 64, Issue 14, 2004, Pages 5013-5019

  Bau, Da Tian ^a   Fu, Yi Ping ^a   Chen, Shou Tung ^c   Cheng, Ting Chih ^a   Yu, Jyh Cherng ^d   Wu, Pei Ei ^a   Shen, Chen Yang ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DOUBLE STRANDED DNA; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA MODIFICATION; DNA REPAIR; DNA STRAND BREAKAGE; FIBROBLAST; GENE; GENE ACTIVITY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSFECTION; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHOMOLOGOUS END JOINING GENE; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BRCA1 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 3142695504     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0403     Document Type: Article

References (33)

1. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003;3:695-701.
2. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001;61:3230-9.
3. Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature (Lond.) 2001;411:366-74.
4. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-54.
5. van Gent DC, Hoeijmakers JHJ, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2001;2:196-206.
6. Shen CY, Yu JC, Lo YL, et al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma - an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 2000;60:3884-92.
7. Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003;22:5784-91.
8. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002;108:171-82.
9. O'Driscoll M, Cerosaletti KM, Girard PM, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001;8:1175-85.
10. Li L, Moshous D, Zhou Y, et al. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J Immunol 2002;168:6323-9.
11. Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 2003;63:2440-6.
12. Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res 2002;30:3295-311.
13. Zhong Q, Boyer TG, Chen PL, Lee WH. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 2002;62:3966-70.
14. Zhong Q, Chen CF, Chen PL, Lee WH. BRCA1 facilitates microhomology- mediated end joining of DNA double strand breaks. J Biol Chem 2002;277:28641-7.
15. Dunning AM, Chiano M, Smith NR, et al. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 1997;6:285-9.
16. Syvänen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet 2001;2:930-42.
17. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Boston: PWS-KENT Publishing Company; 1998.
18. Khoury M. Genetic epidemiology. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1998. p. 609-21.
19. Rebbeck TR. Epidemiological approaches to the identification of cancer predisposition genes. In: El-Deiry WS, editor. Tumor suppressor genes, pathways and isolation strategies, Vol 1. Totowa, New Jersey: Humana Press, Inc.; 2003. p. 309-25.
20. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Ann Rev Pharmacol Toxicol 1996;36:203-32.
21. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999;59:4870-5.
22. Bau DT, Gurr JR, Jan KY. Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision. Carcinogenesis (Lond.) 2001;22:709-16.
23. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002;21:8981-93.
24. West SC. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 2003;4:435-45.
25. Strachan T, Read AP. Human molecular genetics. New York: John Wiley & Sons, Inc.; 1996.
26. Coupier I, Baldeyron C, Rousseau A, et al. Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations. Oncogene 2004;23:914-9.
27. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr Opin Cell Biol 2003;15:345-50.
28. Chen JJ, Silver D, Cantor S, Livingston DM, Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 1999;59:1752s-6s.
29. Zhong Q, Chen CF, Li S, et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (Wash. DC) 1999;285:747-50.
30. D'Amours D, Jackson SP. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol 2002;3:317-27.
31. Deng CX, Wang RH. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet 2003;12:R113-23.
32. Cheng CW, Wu PE, Yu JC, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001;20:3814-23.
33. Hughes-Davies L, Huntsman D, Ruas M, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003;115:523-35.